IMUNON INC (IMNN) Stock Income Statement
USA - NASDAQ:IMNN - US15117N7012 - Common Stock
4.85 USD
-0.06 (-1.22%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 500.00K | 500.00K | |||
| Operating Expenses | 16.02M | 19.00M | 21.03M | 25.42M | 21.51M | |||
| Research and Development | 8.92M | N/A | 11.29M | 11.73M | 10.62M | |||
| Selling, General, and Administrative Expenses | 7.10M | 7.49M | 9.74M | 13.69M | 10.89M | |||
| Operating Income | -16.02M | -19.00M | -21.03M | -24.92M | -21.01M | |||
| Interest Income/Expense | 275.10K | N/A | 960.60K | -4.58M | -560.00K | |||
| Other Income/Expense | N/A | N/A | -396.30K | 5.40M | 1.62M | |||
| Non Recurring Items | N/A | N/A | -329.20K | -13.37M | -2.21M | |||
| Income Before Taxes | -15.75M | -19.00M | -20.80M | -37.47M | -22.15M | |||
| Income Tax | N/A | 0.00 | -1.28M | -1.57M | -1.38M | |||
| Net Income | -15.75M | -19.00M | -19.52M | -35.90M | -20.77M | |||
| EBITDA | -15.08M | -18.28M | -20.31M | -24.19M | -20.31M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -13.56 | -21.53 | -28.14 | -65.55 | -49.91 | |||
| Non GAAP EPS | -14.52 | -16.17 | -2.18 | -5.17 | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -7180.00% | -4154.00% | |||
| Operating Profit Margin | N/A | N/A | N/A | -4984.00% | -4202.00% | |||
All data in USD